or Try an Advanced Search...

    Johnson & Johnson Stocks List

    Symbol Grade Name % Change
    KVUE A Kenvue Inc. 1.30
    JNJ C Johnson & Johnson 1.56
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Household & Personal Products
    Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology Infection

    Related ETFs - A few ETFs which own one or more of the above listed Johnson & Johnson stocks.

    Symbol Grade Name Weight
    IHE D iShares U.S. Pharmaceutical ETF 22.25
    IPO B Renaissance IPO ETF 9.28
    KNGS D Roundhill S&P Dividend Monarchs ETF 9.2
    FLV A American Century Focused Large Cap Value ETF 9.07
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.95
    View all Johnson & Johnson ETFs...
    Compare ETFs
    Compare IHE to FTXH Compare IPO to FLV Compare IPO to FTXH

        Johnson & Johnson Stocks Recent News

        Date Stock Title
        Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
        Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
        Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
        Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
        Nov 19 JNJ J&J pill clears skin in two late-stage psoriasis studies
        Nov 19 JNJ Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
        Nov 18 JNJ J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis
        Nov 18 JNJ Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
        Nov 18 JNJ Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)
        Nov 18 JNJ How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
        Nov 18 JNJ Johnson & Johnson appoints CIO to lead business technology strategy
        Nov 18 JNJ CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
        Nov 18 JNJ Eli Lilly follows J&J in suing Biden administration over 340B rebates
        Nov 15 JNJ U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
        Nov 15 JNJ Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
        Nov 15 JNJ Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says
        Nov 15 KVUE There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings
        Nov 15 JNJ Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program
        Nov 15 JNJ Johnson & Johnson MedTech announces partnership for soft tissue solutions
        Nov 15 JNJ This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
        Related Industries: Drug Manufacturers - Major Household & Personal Products
        Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology Infection
        Johnson & Johnson

        Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
        Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015.
        Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.

        More about Johnson & Johnson
        Browse All Tags